These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17253544

  • 1. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005166. PubMed ID: 17253544
    [Abstract] [Full Text] [Related]

  • 2. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H.
    Cochrane Database Syst Rev; 2013 Dec 27; (12):CD008623. PubMed ID: 24374462
    [Abstract] [Full Text] [Related]

  • 3. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
    Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, Sattar N, Fraser A, Waugh N.
    Health Technol Assess; 2011 Nov 27; 15(38):1-110. PubMed ID: 22059955
    [Abstract] [Full Text] [Related]

  • 4. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
    Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F.
    Cochrane Database Syst Rev; 2007 Jan 24; 2007(1):CD004996. PubMed ID: 17253535
    [Abstract] [Full Text] [Related]

  • 5. Herbal medicines for fatty liver diseases.
    Liu ZL, Xie LZ, Zhu J, Li GQ, Grant SJ, Liu JP.
    Cochrane Database Syst Rev; 2013 Aug 24; (8):CD009059. PubMed ID: 23975682
    [Abstract] [Full Text] [Related]

  • 6. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G.
    Am J Gastroenterol; 2005 May 24; 100(5):1082-90. PubMed ID: 15842582
    [Abstract] [Full Text] [Related]

  • 7. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
    Orlando R, Azzalini L, Orando S, Lirussi F.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD005160. PubMed ID: 17253541
    [Abstract] [Full Text] [Related]

  • 8. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R, Mizrak D, Corapcioglu D, Bektas M, Doganay B, Sayki M, Coban S, Erden E, Soykan I, Emral R, Uysal AR, Ozden A.
    Aliment Pharmacol Ther; 2008 Jul 24; 28(2):200-8. PubMed ID: 18445142
    [Abstract] [Full Text] [Related]

  • 9. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
    Jalali M, Rahimlou M, Mahmoodi M, Moosavian SP, Symonds ME, Jalali R, Zare M, Imanieh MH, Stasi C.
    Pharmacol Res; 2020 Sep 24; 159():104799. PubMed ID: 32278041
    [Abstract] [Full Text] [Related]

  • 10. Weight reduction for non-alcoholic fatty liver disease.
    Peng L, Wang J, Li F.
    Cochrane Database Syst Rev; 2011 Jun 15; (6):CD003619. PubMed ID: 21678341
    [Abstract] [Full Text] [Related]

  • 11. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M.
    Nutrition; 2015 Jun 15; 31(7-8):923-30. PubMed ID: 26059365
    [Abstract] [Full Text] [Related]

  • 12. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
    Said A, Akhter A.
    Ann Hepatol; 2017 Jun 15; 16(4):538-547. PubMed ID: 28611274
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
    Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H.
    J Pediatr Gastroenterol Nutr; 2009 May 15; 48(5):587-96. PubMed ID: 19412008
    [Abstract] [Full Text] [Related]

  • 14. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.
    Metabolism; 2017 Jun 15; 71():17-32. PubMed ID: 28521870
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM, Zhang GY, Wang T, Zhong HJ, Chen WK.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1279-83. PubMed ID: 16796890
    [Abstract] [Full Text] [Related]

  • 16. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Panahi Y, Ghamarchehreh ME, Beiraghdar F, Zare R, Jalalian HR, Sahebkar A.
    Hepatogastroenterology; 2012 Oct 16; 59(119):2099-2103. PubMed ID: 23234816
    [Abstract] [Full Text] [Related]

  • 17. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
    Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, Nonalcoholic Steatohepatitis Clinical Research Network.
    JAMA; 2011 Apr 27; 305(16):1659-68. PubMed ID: 21521847
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bariatric surgery for non-alcoholic steatohepatitis in obese patients.
    Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M.
    Cochrane Database Syst Rev; 2010 Jan 20; 2010(1):CD007340. PubMed ID: 20091629
    [Abstract] [Full Text] [Related]

  • 20. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.
    Clin Ther; 2008 Jun 20; 30(6):1168-76. PubMed ID: 18640473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.